RIM
PFE icon

Redpoint Investment Management’s Pfizer PFE Stock Holding History

Redpoint Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$5.42M Sell
123,853
-18,061
-13% -$878K 0.79% 18
2022
Q2 		$7.44M Hold
141,914
– – 0.88% 14
2022
Q1 		$7.35M Buy
141,914
+12,238
+9% +$635K 0.74% 17
2021
Q4 		$7.66M Sell
129,676
-13,729
-10% -$680K 0.61% 26
2021
Q3 		$6.17M Sell
143,405
-1,747
-1% -$77.4K 0.53% 34
2021
Q2 		$5.68M Buy
145,152
+709
+0.5% +$27.6K 0.46% 40
2021
Q1 		$5.23M Buy
144,443
+1,074
+0.7% +$38.1K 0.44% 47
2020
Q4 		$5.28M Buy
143,369
+304
+0.2% +$11.2K 0.54% 37
2020
Q3 		$4.98M Sell
143,065
-191,982
-57% -$6.73M 0.54% 41
2020
Q2 		$10.4M Sell
335,047
-27,306
-8% -$928K 0.57% 33
2020
Q1 		$11.2M Sell
362,353
-23,237
-6% -$792K 0.7% 24
2019
Q4 		$14.3M Sell
385,590
-3,652
-0.9% -$130K 0.7% 26
2019
Q3 		$13.3M Sell
389,242
-37,910
-9% -$1.38M 0.7% 29
2019
Q2 		$17.6M Sell
427,152
-34,727
-8% -$1.38M 0.93% 14
2019
Q1 		$18.6M Buy
461,879
+13,153
+3% +$527K 0.93% 16
2018
Q4 		$18.6M Buy
448,726
+3,200
+0.7% +$133K 1.08% 10
2018
Q3 		$18.6M Sell
445,526
-25,404
-5% -$978K 0.94% 13
2018
Q2 		$16.2M Sell
470,930
-928
-0.2% -$31.7K 0.88% 19
2018
Q1 		$15.9M Buy
471,858
+3,178
+0.7% +$109K 0.88% 16
2017
Q4 		$16.1M Buy
+468,680
New +$16M 0.89% 18

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Redpoint Investment Management's PFE Position: Q3 2022 in Review

Redpoint Investment Management reduced its Pfizer (PFE) stake by 13% in Q3 2022, selling an estimated $878K and leaving 123,853 shares worth $5.42M. The position accounts for 0.79% of the portfolio, ranked #18.

Redpoint Investment Management first reported a position in PFE in Q4 2017 and has held it in 20 quarters since. The position peaked at $18.6M in Q3 2018. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Redpoint Investment Management held 123,853 shares of Pfizer worth $5.42M as of Q3 2022.
  • Redpoint Investment Management sold 18,061 Pfizer shares in Q3 2022, an estimated $878K.
  • Pfizer made up 0.79% of Redpoint Investment Management's portfolio in Q3 2022, its #18 holding.
  • Redpoint Investment Management first reported a position in Pfizer in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Pfizer position peaked at $18.6M in Q3 2018.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.